D-0154-2024 Class II Ongoing
FDA drug recall D-0154-2024 was initiated by Fagron, Inc on Dec 11, 2023 and is designated Class II. Reason for recall: Labeling: Label Error on Declared Strength: Assay value on the label is incorrect. The recall status is ongoing. Affected quantity: 13 containers.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 27, 2023
- Initiation Date
- Dec 11, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 13 containers
Product description
NYSTATIN 5BU, Activity (as is): 6482 Units/mg, bulk powder container, Rx Only, For Prescription Compounding, Fagron, Inc. - 2400 Pilot Knob Rd. St Paul, MN 55120. NDC 51552-0041-5 Bar code 3 51552 00415 3
Reason for recall
Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.
Distribution pattern
Product was distributed to 1 distributor and may have further distributed the product to repacker/relabelers and pharmacies in the United States and Canada to be used for prescription compounding.
Code information
Lot#: 230308-U46196, Exp. date 04/30/2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0154-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026